This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

IntelliPharmaCeutics International Inc (IPCI)

NASDAQ: Health Care

Company Balance Sheet
Nov 2013 Nov 2012 Nov 2011 Nov 2010
Assets
Cash and Equivalents 760.59K 497.02K 4.82M 789.14K
Receivables 1.66M 304.71K 353.24K 1.19M
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 2.73M 939.18K 5.30M 2.12M
Property, Plant & Equipment, Gross 4.24M 4.53M 3.50M 3.24M
Accumulated Depreciation & Depletion 3.01M 3.00M 2.54M 2.32M
Property, Plant & Equipment, Net 1.23M 1.54M 951.91K 925.55K
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 419.78K 0.00 0.00 224.67K
Total Non-Current Assets 1.65M 1.54M 951.91K 1.15M
Liabilities & Shareholder Equity
Total Assets 4.38M 2.47M 6.25M 3.27M
Accounts Payable 1.57M 1.96M 1.31M 2.25M
Short Term Debt 43.26K 51.52K 43.38K 13.23K
Other Current Liabilities 0.00 0.00 0.00 0.00
Total Current Liabilities 2.79M 2.24M 2.53M 3.16M
Long Term Debt 2.11M 0.00 0.00 0.00
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 5.44M 1.96M 6.72M 16.07K
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 7.54M 2.01M 6.81M 16.07K
Total Liabilities 10.33M 4.24M 9.34M 3.17M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity -5.96M -1.77M -3.09M 92.96K
Common Par 0.00 0.00 0.00 0.00
Additional Paid In Capital 35.34M 28.56M 20.97M 19.39M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -41.58M -30.08M -23.95M -19.07M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 284.42K -240.01K -115.04K -225.48K
Total Capitalization -3.85M -1.77M -3.09M 92.96K
Total Equity -5.96M -1.77M -3.09M 92.96K
Total Liabilities & Stock Equity 4.38M 2.47M 6.25M 3.27M
Total Common Shares Outstanding 21.43M 17.91M 15.91M 10.91M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 19.67M 17.26M 14.99M 10.91M
Diluted Weighted Shares Outstanding 19.67M 17.26M 14.99M 10.91M
Number of Employees 38 39 NA 29
Number of Part-Time Employees 0 0 NA 0
IPCI News

IPCI IntelliPharmaCeutics International Inc

Analysts Ratings for IPCI

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 3 3
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET IPCI ANALYST REPORT

Brokerage Partners

IPCI Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs